Sponsors and Exhibitors
Sponsors and Exhibitors
Accredo Health Group
Accredo is a specialty pharmacy serving patients with complex and chronic health conditions. Our specialty-trained pharmacists and nurses are available to provide personalized care. Accredo’s 14 condition-specific Therapeutic Resource Centers deliver
a level of support and expertise that is unmatched.
Contact Janelle Hahn firstname.lastname@example.org
Alliance Rx Walgreens + PRIME
AllianceRx Walgreens Prime has a dedicated team to service to the Pulmonary Fibrosis (PF) community. We understand how complex the PF journey can be, and we’re ready to support you and your patients every step of the way. Come visit us to learn
how, when it comes to PF, we provide hope and care for better tomorrows.
Apria Healthcare is one of the nation’s leading providers of home respiratory services and certain medical equipment, including oxygen therapy, inhalation therapies, sleep apnea treatment, and negative pressure wound therapy. Apria operates more
than 290 service locations throughout the US and serves more than 2 million patients each year.
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 50,000 employees. For more information please visit www.boehringer-ingelheim.us, or
follow us on Twitter @BoehringerUS.
Heather Dubrosky email@example.com
Underlying Celgene’s commitment to improve the lives of patients worldwide is our dedication to change the course of human health through bold pursuits in science and a promise to always put patients first.
Jaye Bea Smalley firstname.lastname@example.org
CVS Specialty helps patients manage their Ofev and Esbriet by offering the ability to pick up their medication at any CVS retail location. Patients can refill prescriptions and check order status from their phone or computer as well as talk to a pharmacist
and nurse specially trained in PF.
Trevor Piotti Trevor.Piotti@CVSHealth.com
FibroGen, Inc.FibroGen is a biopharmaceutical company focused on the development of innovative medicines for serious and life-threatening conditions. In Phase 3 clinical development for the treatment of IPF, pamrevlumab is a therapeutic antibody that inhibits CTGF in fibrosis and fibroproliferative disease.
FLUIDDA, Inc.Fluidda is the inventor of Functional Respiratory Imaging. This technique combines HRCT-scans and Computational Fluid Dynamics technology, thus offering vast improvements in making clinical trials shorter, faster and cost efficient.
Huub Koets email@example.com